Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

metastatic Soft Tissue Sarcoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Metastatic disease

Broader topic: Soft Tissue Sarcoma

Source population
Not part of this definition
Disease extent
metastatic
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
      source wording
      Metastatic disease

      Study evidence for this setting

      28 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00112463 · Registry condition search · Scope: unclear

      Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00245102 · Registry condition search · Scope: unclear

      Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma

      1 outcome links · 6 safety-group records · 0 quality-of-life measures

      →

      NCT00346164 · Source cited / selected · Scope: unclear

      Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

      6 outcome links · 4 safety-group records · 0 quality-of-life measures

      →

      NCT00390234 · Registry condition search · Scope: unclear

      Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

      5 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00400569 · Registry condition search · Scope: unclear

      Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00525057 · Registry condition search · Scope: unclear

      Dalteparin in Preventing DVT in Participants With Cancer

      3 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00629343 · Registry condition search · Scope: unclear

      Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

      2 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT00659360 · Registry condition search · Scope: unclear

      AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01055314 · Source cited / selected · Scope: unclear

      Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma

      5 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01079832 · Registry condition search · Scope: unclear

      Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

      5 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT01154452 · Registry condition search · Scope: unclear

      Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma

      3 outcome links · 4 safety-group records · 0 quality-of-life measures

      →

      NCT01231906 · Source cited / selected · Scope: unclear

      Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01532687 · Registry condition search · Scope: unclear

      Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

      4 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT01553539 · Registry condition search · Scope: unclear

      Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

      5 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT01586104 · Registry condition search · Scope: unclear

      Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01653028 · Registry condition search · Scope: unclear

      Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

      4 outcome links · 5 safety-group records · 0 quality-of-life measures

      →

      NCT02180867 · Source cited / selected · Scope: unclear

      Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can

      6 outcome links · 7 safety-group records · 2 quality-of-life measures

      →

      NCT02451943 · Registry condition search · Scope: unclear

      A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma

      6 outcome links · 2 safety-group records · 3 quality-of-life measures

      →

      NCT02500797 · Source cited / selected · Scope: unclear

      Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

      6 outcome links · 8 safety-group records · 0 quality-of-life measures

      →

      NCT02584309 · Registry condition search · Scope: unclear

      Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

      5 outcome links · 2 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
        mappings

          Download this complete draft source relationship record →

          Preserved source evidence · Not medical advice